Bisphosphonate Therapy for HIV-Infected Adults With Decreased Bone Mineral Density
Status:
Unknown status
Trial end date:
2009-12-01
Target enrollment:
Participant gender:
Summary
Bisphosphonates are a type of drug used to prevent and treat bone loss. The purpose of this
study is to determine if zoledronate, an investigational bisphosphonate, can improve bone
mineral density (BMD) in HIV-infected adults.
Study hypothesis: Zoledronate will reduce bone resorption in HIV-infected persons with
osteopenia.
Phase:
Phase 2
Details
Lead Sponsor:
National Institute of Allergy and Infectious Diseases (NIAID)